Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05327959 · ClinicalTrials.gov registry record · NA
A.L.P.S. Clavicle Plating System PMCF
A NA study of Clavicle Fracture and Clavicle Injury, sponsored by Zimmer Biomet.
- Active
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 5
- Study locations
NCT05327959: Active NA study of Clavicle Fracture and Clavicle Injury, sponsored by Zimmer Biomet.
NCT05327959 is a NA study of Clavicle Fracture and Clavicle Injury that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05327959, a NA study of Clavicle Fracture and Clavicle Injury, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 5
- Study locations
Study Summary
A commercially available product clinical study which aims to confirm the safety, performance, and clinical benefits to the patient of the ALPS Clavicle Plating system for both the implant itself and the instrumentation used during surgery.
Primary Outcome
Number of subjects with fracture healing will be assessed through 12 months follow-up. Radiologic fracture healing is defined as: Bridging callus or no visible fracture lines on AP and 15-45° cephalic oblique radiographs.
Conditions Studied
Interventions
- DEVICE Clavicle open reduction and internal fixation
Study Locations (5)
Florida
- Cleveland Clinic Florida - Weston
Michigan
- University of Michigan - Michigan Medicine - Ann Arbor
Oregon
- Slocum Research & Education Foundation - Eugene
Texas
- University of Texas San Antonio - San Antonio
Other
- General Foundation of the University of Valladolid - Valladolid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2022-05-13 |
| Est. Completion | 2027-03 |
| Phase | NA |
What the registry record for NCT05327959 still lists
NCT05327959 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Clavicle Fracture appearing as the primary indexed condition, and to 1 intervention - of which Clavicle open reduction and internal fixation is the first listed.
NCT05327959 lists 5 locations in 5 states (Florida, Michigan, Oregon).
Frequently Asked Questions
What is clinical trial NCT05327959 about?
NCT05327959 is a clinical study titled "A.L.P.S. Clavicle Plating System PMCF". A commercially available product clinical study which aims to confirm the safety, performance, and clinical benefits to the patient of the ALPS Clavicle Plating system for both the implant itself and the instrumentation used during surgery.
What is the current status of trial NCT05327959?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 98 participants. The study started on 2022-05-13. Estimated completion is 2027-03.
What conditions does trial NCT05327959 study?
This clinical trial studies the following conditions: Clavicle Fracture, Clavicle Injury.
What interventions are being tested in trial NCT05327959?
The interventions under investigation include: Clavicle open reduction and internal fixation (DEVICE).
Who is sponsoring clinical trial NCT05327959?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05327959 being conducted?
This trial has 5 study locations across Florida, Michigan, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clavicle Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05327959's enrollment target sits among peer trials
98 922nd of 2000 higher than 1,078 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI